Norman J. Lacayo
Affiliations: | Pediatrics - Hematology & Oncology | Stanford University School of Medicine, Palo Alto, CA, United States |
Google:
"Norman Lacayo"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen KG, Duran GE, Mogul MJ, et al. (2020) Genomic stability at the coding regions of the multidrug transporter gene : insights into the development of alternative drug resistance mechanisms in human leukemia cells. Cancer Drug Resistance (Alhambra, Calif.). 3: 959-979 |
| Karol SE, Cooper TM, Mead PE, et al. (2020) Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia. Cancer |
| Chae HD, Dutta R, Tiu B, et al. (2020) RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit. Oncotarget. 11: 2387-2403 |
| Wojcicki AV, Kasowski MM, Sakamoto KM, et al. (2020) Metabolomics in acute myeloid leukemia. Molecular Genetics and Metabolism |
| Karol SE, Alexander TB, Budhraja A, et al. (2020) Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study. The Lancet. Oncology |
| Wojcicki AV, Kadapakkam M, Frymoyer A, et al. (2020) Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit? Cancers. 12 |
| Brown P, Inaba H, Annesley C, et al. (2020) Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 81-112 |
| Huang M, Zeki J, Sumarsono N, et al. (2020) EPIGENETIC TARGETING OF TERT-ASSOCIATED GENE EXPRESSION SIGNATURE IN HUMAN NEUROBLASTOMA WITH TERT OVEREXPRESSION. Cancer Research |
| Sanders LM, Lyle AG, Beale HC, et al. (2020) Abstract A44: Comparative gene expression analysis for identification and prioritization of therapeutic targets in a cohort of childhood cancers Cancer Research. 80 |
| Rubnitz JE, Lacayo NJ, Inaba H, et al. (2019) Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900327 |